Literature DB >> 21482877

Fred Loe, MD, and the history of trachoma.

Robert M Feibel1.   

Abstract

Trachoma has been one of the most blinding diseases in the history of ophthalmology. From its initial description in antiquity until the late 1930s, no specific treatment or effective cure had been known, and the only expedient had been to destroy the diseased tissue containing the infectious agent, rendering the disease inactive. Virtually all medical, mechanical, and surgical treatments were unsatisfactory, with cure rates of approximately 20%. Therapy for trachoma had barely advanced from the measures used by the ancient Egyptian, Greek, and Roman physicians. All prior therapies became obsolete in 1938 when Fred Loe, MD, working on an American Indian reservation, introduced sulfanilamide as a treatment of trachoma, achieving a 90% cure rate. One of the most unusual aspects of Loe's career was that he had no formal training in ophthalmology and was completely self-taught as an ophthalmologist.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21482877     DOI: 10.1001/archophthalmol.2011.64

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  2 in total

1.  Votive Offerings from Floresti Orthodox Monastery in Romania: An Ophthalmological Lesson from the Eighteenth and Nineteenth Centuries CE.

Authors:  A I Cucu; A Perciaccante; F M Galassi; A Nemtoi; R Bianucci
Journal:  J Relig Health       Date:  2022-04-26

2.  Trachomatous Scarring and Infection With Non-Chlamydia Trachomatis Bacteria in Women in Kongwa, Tanzania.

Authors:  Jacob T Cox; Mabula J Kasubi; Beatriz E Muñoz; Andrea I Zambrano; Gregory S Greene; Harran Mkocha; Meraf A Wolle; Sheila K West
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-06-01       Impact factor: 4.799

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.